In this study, we hypothesized that CyPA/CD147 could promote the progression of renal allograft fibrosis by targeting EMT, which has been identified as a crucial origin of renal fibrosis consequently contributing to the CAD pathogenesis. The gene discussed is PPIA; the disease is renal fibrosis.